Company intelligence / Profile preview

Formula30A

Ownership: Private
Development stage: Commercial

Overview

Formula30A produces premium, all-natural hemp products with physician endorsements reporting positive patient outcomes for sleep, anxiety, and chronic pain management. Their products undergo third-party testing for purity and potency.

Therapeutic areas: PsychiatryNeurology
Modalities: Full spectrum cannabinoidsCBD (Cannabidiol)
Industry: Food & Nutrition

Drug pipeline

2 assets

cannabidiol

Commercial

Indications: Epilepsy, Anxiety, Pain, Sleep disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Medical providers

Beyond the preview

Go deeper on Formula30A.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formula30A.

Explore the full profile